ClinicalTrials.gg
RecruitingNCT06966414Updated May 11, 2025

Effects of Different Timing of Bodyweight High-intensity Exercise on Human Behaviours

An interventional study of Morning exercise and Evening exercise in Physical Activity, Energy Intake and Sedentary Behavior, sponsored by National Taiwan Normal University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-11.

Primary conditionSedentary BehaviorRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sedentary Behavior
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Sedentary Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by National Taiwan Normal University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

The purpose of this project is to investigate the effects of exercise at different times of day on 72-hour eating behaviour, physical activity and sedentary behaviour in physically inactive adults.

Read the detailed description

Eligibility and Consent Confirmation:

Prior to the one-week preliminary test, participants will undergo eligibility screening, including measurements of height, weight, and body composition. After the researchers will provide a detailed explanation of the experimental procedures, participants can decide whether to participate in the study. Eligible participants will complete a set of high-intensity bodyweight exercise to familiarize themselves with the exercise. Subsequently, the researchers will explain the use of pedometers and distributed dietary record forms.

During a one-week preliminary test, participants will be instructed to record their physical activity levels measured in steps, sleep duration including wake-up and sleep times, and dietary behaviours through photographs taken (2 weekdays and 1 weekend day) over a period of 7 consecutive days. Participants will be allowed to take part in this study, once they meet the inclusion criteria: 1) an average daily step count of less than 7,500 over the course of the week and 2) a wake-up time no later than 11:00 AM).

Exercise intervention:

Two main trials will be separated by at least one week - exercise in the morning (08:00 to 11:00 AM) or exercise in the evening (18:00 to 21:00 PM).

In both trials, participants will complete the first Visual Analogue Scale (VAS) for subjective appetite upon waking, wear a pedometer and an accelerometer, and record energy intake and physical activity over a 3-day period (the day before exercise intervention, the exercise day and the day after exercise intervention). Upon arrival at the laboratory, participants will complete the second VAS, followed by a 15-minute waiting period before commencing the exercise. Participants will perform high-intensity bodyweight exercise (3 sets with 8 exercises with a cycle of 30 seconds exercise and 30 seconds rest), followed by a 15-minute rest period, after which they will complete the third VAS.

Heart rate and Rating of Perceived Exertion (RPE) will be measured regularly during exercise. Energy balance (e.g., energy intake and spontaneous physical activity) will be assessed using a food diary, Actigraph wGT3x-BT accelerometer (Actigraph Co., Ltd., Pensacola, FL, USA), and pedometer (Realalt, Goldhat Ltd., UK), which will be worn starting from the night two days before the experiment and removed after waking up two days post-experiment.

02

Conditions studied

  • Physical Activity
  • Energy Intake
  • Sedentary Behavior

Browse trials for

Keywords

  • Timing of exercise
  • Morning exercise
  • Evening exercise
  • Behavioural compensation
03

In context

Sedentary Behavior Reclassified

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's planned enrollment of 20 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

National Taiwan Normal University is the lead sponsor of 64 studies on the registry; 15 are open to participants now.

Compared within Sedentary Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 20 and 50 years, with a ranging from 19 to 27 kg/m².
  • Classified as having "low" physical activity levels (750 Metabolic Equivalents / week) according to the International Physical Activity Questionnaire (IPAQ).
  • Engaged in moderate-intensity exercise for no more than 3 days per week and less than 30 minutes per session in the 3 months preceding the study.
  • Maintained a stable body weight (± 3 kg) during the 3 months prior to the main experiment.
  • Not taking any medications, supplements, or vitamins that might affect food intake, appetite, physical activity, weight loss, or metabolism.
  • Free from cardiovascular and metabolic diseases.
  • Not pregnant or planning to become pregnant.
  • Not currently on a diet or undergoing any specific dietary interventions (e.g., intermittent fasting, ketogenic diet).
  • No injuries or surgical wounds preventing physical activity.
  • Regular sleep patterns, averaging 7-9 hours per night, with no shift work.
  • No habits of heavy alcohol consumption or smoking.

Exclusion criteria

Exclusion Criteria:

  • Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia.
  • Taking medications that may influence lipid or carbohydrate metabolism or immune system function.
  • Unable to take part in exercise for any reason (e.g., injury or disability) or a positive response to any questions on the Physical Activity Readiness questionnaire (PAR-Q).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Morning exercise

    Participants performed bodyweight exercise in the morning between 08:00 to 11:00 AM.

    Behavioral: Morning exercise

  • Experimental
    Evening exercise

    Participants performed bodyweight exercise in the morning between 18:00 to 21:00 PM.

    Behavioral: Evening exercise

Interventions

  • BehavioralMorning exercise

    Participants performed bodyweight exercise in the morning between 08:00 to 11:00 AM.

  • BehavioralEvening exercise

    Participants performed bodyweight exercise in the morning between 18:00 to 21:00 PM.

06

What researchers measure

Primary outcomes

  1. Physical activity

    Changes in physical activity intensity (minutes and percentage during 72 hours) and levels (minutes and percentage during 72 hours) between trials

    Time frame: 72 hours (24 hours before exercise day, exercise day and 24 hours after exercise day)

  2. Energy intake

    Changes in total and macronutrient energy intake between trials

    Time frame: 72 hours (24 hours before exercise day, 24 hours during exercise day and 24 hours after exercise day)

  3. Sedentary behaviour

    Changes in sedentary behaviour (minutes and percentage during 72 hours) between trials

    Time frame: 72 hours (24 hours before exercise day, exercise day and 24 hours after exercise day)

Secondary outcomes

  1. Heart Rate

    Changes in heart rate (bmp) during exercise between trials

    Time frame: During 45 minutes exercise

  2. Rating of Perceived Exertion (RPE)

    Changes in Rating of Perceived Exertion using Borg 6-20 scale (6 indicates no exertion and 20 indicates maximal effort) during exercise between trials

    Time frame: During 45 minutes exercise

  3. Visual analogue scale (VAS)

    Changes in Visual analogue scale (Mood and appetite) using 0-100 mm scale (0 indicates not at all and 100 indicates very much) during exercise between trials

    Time frame: Baseline upon wake up, 15 minutes before exercise and 15 minutes after exercise

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Apr 2026, 11 months after the start.

Of 733 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 11 months is below that.

Counting every sponsor, half of 741 studies reached it within 14 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2025
First posted
May 11, 2025
StartActual
Apr 30, 2025
Primary completionEst.
Apr 24, 2026
CompletionEst.
Apr 24, 2026
Last update
May 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06966414
Lead sponsor
National Taiwan Normal University
Responsible party
Yung-Chih Chen (Principal Investigator, National Taiwan Normal University) — Principal investigator
First posted
May 11, 2025
Start date
Apr 30, 2025
Primary completion
Apr 24, 2026 (estimated)
Completion
Apr 24, 2026 (estimated)
Last update
May 11, 2025

Study contacts

Yung-Chih Chen, PhD
Contact
yc.chen@ntnu.edu.tw
Chen, PhD
Contact
+886-2-77496979

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion